SCS Capital Management LLC Has $1.47 Million Stake in SPDR S&P Biotech ETF $XBI

SCS Capital Management LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,070 shares of the exchange traded fund’s stock after selling 9,562 shares during the period. SCS Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,472,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of XBI. Legacy Wealth Managment LLC ID bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $32,000. Ballast Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $36,000. Creative Financial Designs Inc. ADV bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $39,000. Barnes Dennig Private Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $48,000. Finally, Navalign LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $48,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $133.62 on Tuesday. The firm has a market capitalization of $8.52 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The business’s fifty day moving average price is $131.22 and its two-hundred day moving average price is $126.19. SPDR S&P Biotech ETF has a 52 week low of $79.49 and a 52 week high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.